Aspera Biomedicines, Inc
Total Awards:
2
Award Value:
$7,199,892
Institution type:
For profit
Short Name:
Aspera Biomedicines, Inc
Awards to the Institution
| Program Type | Investigator | Grant Title | Award Value |
|---|---|---|---|
| Clinical Trial Stage Projects | Curtis Scribner | Rebecsinib, an RNA Splicing and Base Editing Inhibitor to Target Cancer Stem Cells in Refractory Myeloid Malignancies | $3,999,892 |
| Late Stage Preclinical Projects | Catriona Jamieson | Cancer Stem Cell Interception with Rebecsinib: A First-in-Class ADAR1 Inhibitor | $3,200,000 |
| Total: $7,199,892.00 |